Loading organizations...
Molecular testing platform for healthcare diagnostics using synthetic biolo
En Carta Diagnostics has raised $1.6M across 1 funding round.
En Carta Diagnostics has raised $1.6M in total across 1 funding round.
En Carta Diagnostics has raised $1.6M in total across 1 funding round.
En Carta Diagnostics's investors include Cédric Curtil.
En Carta Diagnostics has raised $1.6M across 1 funding round. Most recently, it raised $1.6M Pre-Seed in May 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 22, 2024 | $1.6M Pre-Seed | Cédric Curtil |